FJPNX | FPJAX | FJPNX / FPJAX | |
Total Expense Ratio | 0.66 | 0.95 | 69% |
Annual Report Gross Expense Ratio | 0.66 | 0.95 | 69% |
Fund Existence | 33 years | 15 years | - |
Gain YTD | 18.011 | 17.899 | 101% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 763M | 763M | 100% |
Annual Yield % from dividends | 2.28 | 2.00 | 114% |
Returns for 1 year | 19.03 | 18.69 | 102% |
Returns for 3 years | 44.46 | 43.19 | 103% |
Returns for 5 years | 30.91 | 29.69 | 104% |
Returns for 10 years | 69.89 | 68.19 | 102% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LIRRX | 9.53 | 0.07 | +0.74% |
Lord Abbett International Value R3 | |||
NSFDX | 8.99 | 0.01 | +0.11% |
Natixis Target Retirement 2020 N | |||
AASOX | 16.95 | -0.01 | -0.06% |
Alger Small Cap Growth I-2 | |||
ASVYX | 9.84 | -0.02 | -0.20% |
American Century Small Cap Value Y | |||
FIJYX | 28.77 | -0.21 | -0.72% |
Fidelity Advisor Biotechnology Z |